<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We prospectively evaluated the neuropathological complications of 180 patients who underwent autopsy studies following bone marrow transplantation (BMT) (177 allogeneic, three autologous) </plain></SENT>
<SENT sid="1" pm="."><plain>The most frequent underlying disorders included severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (n = 55), <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> (n = 53), <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (n = 24) and Fanconi <z:hpo ids='HP_0001903'>anemia</z:hpo> (n = 16) </plain></SENT>
<SENT sid="2" pm="."><plain>There were 114 males and 66 females </plain></SENT>
<SENT sid="3" pm="."><plain>Neuropathological findings were detected in 90.55% of the patients </plain></SENT>
<SENT sid="4" pm="."><plain>The most frequent findings were <z:hpo ids='HP_0002138'>subarachnoid hemorrhages</z:hpo> (SAH) (n = 57), intraparenchymal <z:mp ids='MP_0001914'>hemorrhages</z:mp> (IHP) (n = 49), <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infections</z:e> (n = 16), Wernicke's <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> (n = 10), microglial nodular <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> (n = 10) and <z:e sem="disease" ids="C0751631" disease_type="Disease or Syndrome" abbrv="">neurotoxoplasmosis</z:e> (n = 8) </plain></SENT>
<SENT sid="5" pm="."><plain>In only 17 patients was the brain within <z:mpath ids='MPATH_458'>normal</z:mpath> limits </plain></SENT>
<SENT sid="6" pm="."><plain>Survival time after BMT averaged 5.4 months and the majority of patients died in the first 3 months post BMT (n = 105) </plain></SENT>
<SENT sid="7" pm="."><plain>Central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) pathology was the main cause of <z:hpo ids='HP_0011420'>death</z:hpo> in 17% of the patients (n = 31), with a predominance of IHP in this particular group </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, the survival time of these patients who died of <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> causes (96.3 days) was almost half of the survival time of those who died of extra-cerebral causes (177.8 days) (P = 0.0162) </plain></SENT>
<SENT sid="9" pm="."><plain>IHP (70 </plain></SENT>
<SENT sid="10" pm="."><plain>96 vs27.22%) (P &lt; 0.001), <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infections</z:e> (25.8 vs 8.88%) (P &lt; 0 </plain></SENT>
<SENT sid="11" pm="."><plain>001) and <z:e sem="disease" ids="C0040558" disease_type="Disease or Syndrome" abbrv="">toxoplasmosis</z:e> (9.67 vs 4.44%) (P &lt; 0.001) were significantly more frequent in the group of patients who died due to <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> causes than in the control group </plain></SENT>
<SENT sid="12" pm="."><plain>The findings of this work provide a possible guide to the possible causes of neurological syndromes following BMT </plain></SENT>
<SENT sid="13" pm="."><plain>Bone Marrow Transplantation (2000) 25, 301-307 </plain></SENT>
</text></document>